USP1 and pachyonychia congenita: Importantly, the immunoblot analysis further displayed that the combination of enzalutamide and SNS-032 notably reduced expressions of USP1, SIX1, AR and AR-V7 (Fig. 6E), which are key players for the growth and castration resistance of PC.